Protected: IgNS 2025 National Conference CE/CME Session Evaluations
Password Protected
To view this protected post, enter the password below:
Beyond Infection: The Realities of Primary Immunodeficiency | Webinar Series
Provided by the Ig National Society, Inc. Original Release Date: June 24, 2025 Expiration Date: June 24, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who may treat patients with primary immunodeficiencies. Educational...When Headaches Speak Louder: Unmasking Aseptic Meningitis in Immunoglobulin Therapy
Provided by the Ig National Society, Inc. Original Release Date: May 28, 2025 Expiration Date: May 28, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who treat patients that may be at risk of aseptic meningitis. Educational...Bronchiectasis in Primary Immunodeficiency
Provided by the Ig National Society, Inc. Original Release Date: May 23, 2025 Expiration Date: May 23, 2028 Target Audience This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of...Solid Organ Transplantation
Provided by the Ig National Society, Inc. Original Release Date: May 23, 2025 Expiration Date: May 23, 2028 Target Audience This activity is intended for nurses, pharmacists, and who may use immunoglobulin therapy in solid organ transplant. Educational Objectives...Transcultural Competency – Much More Than You Think
Provided by the Ig National Society, Inc. Original Release Date: May 23, 2025 Expiration Date: May 23, 2028 Target Audience This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of...Updates in Myositis Care: A review of Evidence-Based Practices and Emerging Therapies
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who treat patients with myositis. Educational Objectives Upon...Mast Cell Activation Syndrome
Provided by the Ig National Society, Inc. Original Release Date: May 23, 2025 Expiration Date: May 23, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who treat patients with mast cell activation syndrome. Educational Objectives...WHIM Syndrome
Provided by the Ig National Society, Inc. Original Release Date: May 13, 2025 Expiration Date: May 13, 2028 Target Audience This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients with WHIM syndrome. ...Historical and Modern Advancement in the Treatment of Primary Immune Thrombocytopenia
Provided by the Ig National Society, Inc. Original Release Date: May 23, 2025 Expiration Date: May 23, 2028 Target Audience This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients with primary immune...From Inflammation to Autoimmunity: Tracing the Pathogenesis of Immune-Mediated Disorders
Provided by the Ig National Society, Inc. Original Release Date: May 23, 2025 Expiration Date: May 23, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who treat immune-meditated disorders. Educational Objectives Upon completion...Dermatology Clinical Update: IVIg for Skin Autoimmunity
Provided by the Ig National Society, Inc. Original Release Date: May 13, 2025 Expiration Date: May 13, 2028 Target Audience This activity is intended for nurses, pharmacists and physicians who treat patients who may receive Ig therapy to treat skin autoimmunity....Stevens-Johnson Syndrome
Provided by the Ig National Society, Inc. Original Release Date: May 13, 2025 Expiration Date: May 13, 2028 Target Audience This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients with Stevens-Johnson...Clinical Updates in the Treatment of Autoimmune Disorders of the GI System
Provided by the Ig National Society, Inc. Original Release Date: May 13, 2025 Expiration Date: May 13, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who care for patients with autoimmune disorders of the gastrointestinal...Clinical Update in the Diagnosis, Treatment, and Management of CIDP
Provided by the Ig National Society, Inc. Original Release Date: May 13, 2025 Expiration Date: May 13, 2028 Target Audience This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of...Intersections of Immunity: Exploring the Link Between Primary Immunodeficiencies and Malignancies
Provided by the Ig National Society, Inc. Original Release Date: May 13, 2025 Expiration Date: May 13, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who treat patients with primary immunodeficiences and malignancies. ...Optimizing the SCIG Infusion and Ensuring Patient Success: Focus on Neuromuscular Disorders
Provided by the Ig National Society, Inc. Original Release Date: April 30, 2025 Expiration Date: April 30, 2026 Target Audience This activity is intended for pharmacists, nurses, and physicians who treat patients with neuromuscular disorders. Educational Objectives...Ig Foundations
Provided by the Ig National Society, Inc. Original Release Date: April 30, 2025 Expiration Date: April 30, 2028 Target Audience This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of...Subcutaneous Infusions in Generalized Myasthenia Gravis: Understanding the Administration of Rozanolixizumab-noli
Speakers: Chandra Shaw, ACNP-G Director of Nursing Infusion for HealthGI Complications in the PI Patient
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for pharmacists, nurses, and physicians who care for patients with gastrointestinal complications....Clinical Trials: The Basics of Clinical Research
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for pharmacists, nurses, and physicians who treat patients that may be interested in clinical trials....Recognizing and Reporting Adverse Drug Reactions in Ig Therapy
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for pharmacists, nurses, and physicians who care for patients with potential adverse reactions/side effects....Medical/Clinical Hypnosis: Evidence-Based Therapy for Chronic Pain and More
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for pharmacists, nurses, and physicians caring for patients with chronic pain. Educational Objectives Upon...Peripheral Neuropathies and Foot Care
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for pharmacists, nurses, and physicians who care for patients with peripheral neuropathies. Educational...Biologics and Biosimilars: Understanding the Differences
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for pharmacists, nurses, and physicians who interested in the use of biologics and biosimilars in clinical...IgE-Mediated Allergic Disease: Gell and Combs Type 1 Hypersensitivity Reaction
Provided by the Ig National Society, Inc. Original Release Date: February 17, 2025 Expiration Date: February 17, 2028 Target Audience This activity is intended for pharmacists, nurses, and physicians who have interest in IgE-mediated allergic disease. Educational...Alyglo™ (immune globulin intravenous, human-stwk), 10%: Advancing the IVIG Manufacturing Process with Cation Exchange (CEX) Chromatography
Speakers: Ryan Dorfman, Ph.D. Stacey Ness, PharmD, IgCP®, CSP, MSCS, AAHIVP Suzanne Strasters, MSN-FNP, IgCN®Infusion Medication Safety & Clinical Training
Speakers: Chuck DiTrapano, RPh & Steven Nice In this webinar, participants are introduced to RxToolKit, an innovative software designed to streamline and improve medication management, clinical training, and patient safety. The session begins with a brief history...Understanding Kawasaki Disease: A Comprehensive Overview for Healthcare Professionals
Provided by the Ig National Society, Inc. Original Release Date: March 20, 2025 Expiration Date: March 20, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who care for patients with Kawasaki disease. Educational Objectives Upon...Understanding Stiff Person Syndrome
Provided by the Ig National Society, Inc. Original Release Date: March 20, 2025 Expiration Date: March 20, 2028 Target Audience This activity is intended for nurses, pharmacists, and physicians who care for patients with stiff person syndrome. Educational Objectives...Childhood Post-Infectious Autoimmune Encephalopathy
Jointly provided by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc. Original Release Date: April 19, 2024 Last Review Date: April 19, 2024 Expiration Date: April 19, 2025 Target Audience This activity is intended for pharmacists and...IgCP Review Course-2022
IgCN Review Course-2022
Part 6. Secondary Immune Deficiencies from Biological Agents
Mark Ballow, MD Professor of PediatricsUniversity of South Florida Supported by Educational Grants from Pfizer and Takeda Speaker Additional Sessions Mark Ballow, MD Professor of PediatricsUniversity of South FloridaSupported by educational grants from: Pfizer, Inc...
Part 5. Immune Dysregulation
Jennifer Leiding, MD Director, Multidisciplinary Immunology Services University of South Florida Supported by Educational Grants from Pfizer, Inc and Takeda Speaker Additional Sessions Jennifer Leiding, MD Director, Multidisciplinary Immunology ServicesUniversity of...
Part 4. Pulmonary Complications of Primary Immunodeficiency
PJ Maglione, MD, PhD Assistant Professor Boston University School of Medicine Supported by Educational Grants from Pfizer and Takeda Speaker Additional Sessions PJ Maglione, MD, PhD Assistant Professor Boston University School of MedicineSupported by educational...
Part 3. The Complex Primary Immunodeficient Patient
Richard Wasserman, MD, PhD Medical Director of Pediatric Allergy and ImmunologyMedical City Children’s Hospital Supported by Educational Grantsfrom Pfizer and Takeda Speaker Additional Sessions Richard Wasserman, MD, PhD Medical Director of Pediatric Allergy and...
Part 2. Autoinflammatory Disorders
Lori Broderick, MD, PhD Assistant Professor of Pediatrics University of California in San Diego Supported by Educational Grants from Pfizer and Takeda Speaker Additional Sessions Lori Broderick, MD, PhD Assistant Professor of Pediatrics University of California in San...